India
· Delayed Price · Currency is INR Biocon Statistics
Total Valuation
Biocon has a market cap or net worth of INR 447.25 billion. The enterprise value is 639.18 billion.
| Market Cap | 447.25B |
| Enterprise Value | 639.18B |
Important Dates
The next estimated earnings date is Friday, November 8, 2024.
| Earnings Date | Nov 8, 2024 |
| Ex-Dividend Date | Jul 5, 2024 |
Share Statistics
Biocon has 1.20 billion shares outstanding. The number of shares has increased by 0.18% in one year.
| Shares Outstanding | 1.20B |
| Shares Change (YoY) | +0.18% |
| Shares Change (QoQ) | -0.15% |
| Owned by Insiders (%) | 62.61% |
| Owned by Institutions (%) | 24.69% |
| Float | 443.37M |
Valuation Ratios
The trailing PE ratio is 28.33 and the forward PE ratio is 55.69. Biocon's PEG ratio is 1.81.
| PE Ratio | 28.33 |
| Forward PE | 55.69 |
| PS Ratio | 3.03 |
| PB Ratio | 2.26 |
| P/FCF Ratio | n/a |
| PEG Ratio | 1.81 |
Enterprise Valuation
| EV / Earnings | 40.43 |
| EV / Sales | 4.33 |
| EV / EBITDA | 19.56 |
| EV / EBIT | 40.17 |
| EV / FCF | n/a |
Financial Position
| Current Ratio | n/a |
| Quick Ratio | n/a |
| Debt / Equity | 64.40 |
| Debt / EBITDA | 4.91 |
| Debt / FCF | n/a |
| Interest Coverage | 1.68 |
Financial Efficiency
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | n/a |
| Return on Capital (ROIC) | 2.50% |
| Revenue Per Employee | 9.05M |
| Profits Per Employee | 968,924 |
| Employee Count | 16,315 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +38.72% in the last 52 weeks.
| Beta (5Y) | n/a |
| 52-Week Price Change | +38.72% |
| 50-Day Moving Average | 353.36 |
| 200-Day Moving Average | 297.82 |
| Relative Strength Index (RSI) | 61.93 |
| Average Volume (20 Days) | 5,064,077 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Biocon had revenue of INR 147.66 billion and earned 15.81 billion in profits. Earnings per share was 13.19.
| Revenue | 147.66B |
| Gross Profit | 92.11B |
| Operating Income | 16.42B |
| Pretax Income | 24.87B |
| Net Income | 15.81B |
| EBITDA | 32.72B |
| EBIT | 16.42B |
| Earnings Per Share (EPS) | 13.19 |
Balance Sheet
The company has 25.74 billion in cash and 162.77 billion in debt, giving a net cash position of -137.03 billion or -114.49 per share.
| Cash & Cash Equivalents | 25.74B |
| Total Debt | 162.77B |
| Net Cash | -137.03B |
| Net Cash Per Share | -114.49 |
| Equity (Book Value) | 252.75B |
| Book Value Per Share | 165.30 |
| Working Capital | n/a |
Cash Flow
| Operating Cash Flow | n/a |
| Capital Expenditures | n/a |
| Free Cash Flow | n/a |
| FCF Per Share | n/a |
Margins
Gross margin is 62.38%, with operating and profit margins of 11.12% and 10.71%.
| Gross Margin | 62.38% |
| Operating Margin | 11.12% |
| Pretax Margin | 16.84% |
| Profit Margin | 10.71% |
| EBITDA Margin | 22.16% |
| EBIT Margin | 11.12% |
| FCF Margin | n/a |
Dividends & Yields
This stock pays an annual dividend of 0.50, which amounts to a dividend yield of 0.13%.
| Dividend Per Share | 0.50 |
| Dividend Yield | 0.13% |
| Dividend Growth (YoY) | -66.67% |
| Years of Dividend Growth | 1 |
| Payout Ratio | n/a |
| Buyback Yield | -0.18% |
| Shareholder Yield | -0.05% |
| Earnings Yield | 3.53% |
| FCF Yield | n/a |
Stock Splits
The last stock split was on June 12, 2019. It was a forward split with a ratio of 2.
| Last Split Date | Jun 12, 2019 |
| Split Type | Forward |
| Split Ratio | 2 |